Advertisement

Topics

ValiRx continues “advanced conversations” with possible partners for VAL401 lung cancer drug

04:13 EDT 14 Jun 2018 | Proactive Investors

ValiRx released the positive results of a phase II trial of its lead drug earlier this year and it is now looking for a partner to help take VAL401 through a phase III study and into the market

Original Article: ValiRx continues “advanced conversations” with possible partners for VAL401 lung cancer drug

NEXT ARTICLE

More From BioPortfolio on "ValiRx continues “advanced conversations” with possible partners for VAL401 lung cancer drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...